Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Completed 2Terminated 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 2Colorectal Neoplasms 2Neuroma, Acoustic 1Neuroma 1Neurilemmoma 1Neoplasms 1Microsatellite-stable Colorectal Cancer 1Meningioma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Astrocytoma 1

Interventions

lutetium Lu 177 dotatate 1Surveys and Questionnaires 1Sunitinib 1Magnetic Resonance Imaging 1Hydroxyurea 1Fertility 1Everolimus 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Meningioma × Bevacizumab × Clear all
NCT06955169 2026-05-22

MOMENTUM-1

RTOG Foundation, Inc.

Phase 2 Suspended
153 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡